Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00826592 · ClinicalTrials.gov registry record · NA

Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis

A NA study of Atopic Dermatitis and Atopic Eczema, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT00826592 is a NA study of Atopic Dermatitis and Atopic Eczema that has completed, run by University of California, Davis. The registered enrollment target is 80 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00826592, a NA study of Atopic Dermatitis and Atopic Eczema, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effect of video-based patient education with written instruction on subjects' knowledge of atopic dermatitis and their disease severity, measured by the Patient-oriented Eczema Measure (POEM), after viewing the educational materials.

Interventions

  • OTHER Patient Educational Materials

Study Locations (1)

California

  • University of California Davis Department of Dermatology - Sacramento

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2009-01
Est. Completion 2009-08
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT00826592

The ClinicalTrials.gov registry entry for NCT00826592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (87% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 1 intervention - of which Patient Educational Materials is the first listed.

NCT00826592 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00826592 about?

NCT00826592 is a clinical study titled "Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis". The purpose of this study is to compare the effect of video-based patient education with written instruction on subjects' knowledge of atopic dermatitis and their disease severity, measured by the Patient-oriented Eczema Measure (POEM), after viewing the educational materials.

What is the current status of trial NCT00826592?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2009-01. Estimated completion is 2009-08.

What conditions does trial NCT00826592 study?

This clinical trial studies the following conditions: Atopic Dermatitis, Atopic Eczema, Infantile Eczema, Hand Eczema.

What interventions are being tested in trial NCT00826592?

The interventions under investigation include: Patient Educational Materials (OTHER).

Who is sponsoring clinical trial NCT00826592?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00826592 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.